Annals On Call: First-line drug therapy for type 2 diabetes
Annals On Call is a podcast focusing on a clinically influential article published in Annals of Internal Medicine. A recent episode covered a study of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists as first-line therapy.
The latest episode of Annals On Call, posted Feb. 21, addresses the use of sodium-glucose cotransporter-2 inhibitors or glucagon-like peptide-1 receptor agonists as first-line agents for diabetes. Host Robert Centor, MD, MACP, discusses the topic with Neda Laiteerapong, MD, FACP, and Aaron Winn, PhD.
Annals On Call is a podcast focusing on a clinically influential article from Annals of Internal Medicine, in this case, “First-Line Therapy for Type 2 Diabetes With Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists,” a study by Drs. Laiteerapong, Winn, and colleagues that was published by Annals (and summarized by ACP Diabetes Monthly) in October 2022. In each podcast, Dr. Centor shares his own perspective on the material and interviews experts to discuss, debate, and share diverse insights about patient care and health care delivery.